Simultaneous Fe<sup>2+</sup>/Fe<sup>3+</sup> imaging shows Fe<sup>3+</sup> over Fe<sup>2+</sup> enrichment in Alzheimer's disease mouse brain.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37075105.
- Also identified by DOI 10.1126/sciadv.ade7622 and PMC identifier 10115418.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Visualizing redox-active metal ions, such as Fe<sup>2+</sup> and Fe<sup>3+</sup> ions, are essential for understanding their roles in biological processes and human diseases. Despite the development of imaging probes and techniques, imaging both Fe<sup>2+</sup> and Fe<sup>3+</sup> simultaneously in living cells with high selectivity and sensitivity has not been reported. Here, we selected and developed DNAzyme-based fluorescent turn-on sensors that are selective for either Fe<sup>2+</sup> or Fe<sup>3+</sup>, revealing a decreased Fe<sup>3+</sup>/Fe<sup>2+</sup> ratio during ferroptosis and an increased Fe<sup>3+</sup>/Fe<sup>2+</sup> ratio in Alzheimer's disease mouse brain. The elevated Fe<sup>3+</sup>/Fe<sup>2+</sup> ratio was mainly observed in amyloid plaque regions, suggesting a correlation between amyloid plaques and the accumulation of Fe<sup>3+</sup> and/or conversion of Fe<sup>2+</sup> to Fe<sup>3+</sup>. Our sensors can provide deep insights into the biological roles of labile iron redox cycling.
Medical subject headings
- Alzheimer Disease